Nearly three-fourths of the 2.4 million U.S. adults who reported using buprenorphine in 2019 did not misuse the medication in the past 12 months, according to a National Institutes of Health study released last week in JAMA Network Open. The researchers also found a downward trend of buprenorphine misuse between 2015 and 2019 among those with an opioid use disorder. Individuals who received no drug use treatment and those in rural areas were more likely to misuse the medication.

“This study provides further evidence to support the need for expanded access to proven treatment approaches, such as buprenorphine therapy, despite the remaining stigma and prejudice that remains for people with addiction and the medications used to treat it,” said National Institute on Drug Abuse Director Nora Volkow, M.D. 
 

Related News Articles

Headline
The Substance Abuse and Mental Health Services Administration yesterday extended certain methadone take-home flexibilities for opioid treatment programs…
Headline
The Department of Health and Human Services today released an overdose prevention strategy focused on prevention, harm reduction, evidence-based treatment…
Headline
U.S. overdose deaths involving psychostimulants other than cocaine, largely methamphetamine, increased 180% among adults under age 65 between 2015 and 2019, to…
Headline
The Brigham Comprehensive Opioid Response and Education program and McLean Hospital of Belmont, Mass., on Sept. 21 at 12 p.m. ET will host a town hall virtual…
Headline
The Centers for Medicare & Medicaid Services today awarded 20 states American Rescue Plan Act grants to develop and implement mobile crisis…
Headline
The Substance Abuse and Mental Health Services Administration this week awarded $123 million in grants to help health care providers and communities…